Nantahala’s Massive Warrant Buy‑Back Signals Talphera Management’s Bold Confidence in Future Upside.
Talphera’s latest insider buying and pre‑funded warrants signal a bullish view on its acute‑pain pipeline, hinting at future upside above $1.00.
2 minutes to read